Capricor Therapeutics Inc. (CAPR) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Capricor Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$6.23
+2.13% today
Market cap
$355M
Overall quality
45/100
Kronos AI 30-day
+53.4%
8 of 8 simulated paths end higher
Capricor Therapeutics Inc. (CAPR) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $355M. It trades at $6.23, up 2.13% today. Its overall quality score is 45 out of 100, ranked against the whole US market. 10 analysts' average target of $27.00 implies +333.4% from today's price. Kronos AI's 30-day forecast is +53.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $27.00 |
| Low – high | $7.00 – $54.00 |
| Analysts | 10 |
| Upside to average | +333.4% |
Kronos AI 30-day forecast
| Expected close | $9.36 (+53.4%) |
| Likely range | +41.8% … +180.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 39 |
| Solvency | 50 |
| Growth | 46 |
| Overall | 45 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.